PRLD
Prelude Therapeutics Incorporated
Company Overview
| Mkt Cap | $87.16M | Price | $1.59 |
| Volume | 111.38K | Change | +1.27% |
| P/E Ratio | -0.7 | Open | $1.56 |
| Revenue | $7.0M | Prev Close | $1.57 |
| Net Income | $-127.2M | 52W Range | $0.61 - $1.91 |
| Div Yield | N/A | Target | $3.50 |
| Overall | 51 | Value | 60 |
| Quality | 28 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyPrelude Therapeutics Incorporated (PRLD) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $1.59 with a market capitalization of $87.16 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 28.
Today's trading session shows PRLD with a volume of 111K shares. The stock opened down 0.64% from yesterday's close of $1.57. Current analyst estimates project earnings of $-1.51 per share for this year, with next year targeting $-1.24.
PRLD demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for PRLD include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 120.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:04 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRLD | $1.59 | +1.3% | 111.38K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW